Results 1 to 10 of about 1,019,197 (220)
Prevalence of G6PD deficiency and G6PD variants amongst the southern Thai population [PDF]
PeerJ, 2022 Background Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme essential for NADPH production and protecting cells, especially red blood cells, from free radicals.
Manit Nuinoon +7 more
doaj +5 more sources
Molecular epidemiological investigation of G6PD deficiency in Yangjiang region, western Guangdong province [PDF]
Frontiers in Genetics, 2023 Objectives: The prevalence of G6PD deficiency has not been reported in Yangjiang, a western city in Guangdong province. This study aims to investigate the molecular characteristics of G6PD deficiency in this region.Methods: Blood samples were collected ...
Hong-Feng Liang +14 more
doaj +4 more sources
Mediterranean Journal of Hematology and Infectious Diseases, 2021 Introduction: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common X-linked enzymopathy, highly prevalent in areas where malaria is or has been endemic. Prevalence of G6PD deficiency and characterization of G6PD variants in females from
Sumalai Dechyotin +6 more
doaj +4 more sources
Effect of combined G6PD deficiency and diabetes on protein oxidation and lipid peroxidation
BMC Endocrine Disorders, 2021 Background Oxidative Stress, an imbalance in the pro-oxidant/antioxidant homeostasis, occurs in many physiological and non-physiological processes and several human diseases, including diabetes mellitus (DM) and glucose-6-phosphate dehydrogenase (G6PD ...
Naif S. Karadsheh +3 more
doaj +2 more sources
Hematologic and systemic metabolic alterations due to Mediterranean class II G6PD deficiency in mice
JCI Insight, 2021 Deficiency of glucose-6-phosphate dehydrogenase (G6PD) is the single most common enzymopathy, present in approximately 400 million humans (approximately 5%). Its prevalence is hypothesized to be due to conferring resistance to malaria.
Angelo D’Alessandro +13 more
doaj +2 more sources
Frontiers in Pediatrics, 2023 ObjectiveGlucose 6-phosphate dehydrogenase (G6PD) deficiency increases the risk of neonatal hyperbilirubinemia. The aim of this study is to evaluate the risk factors associated with hyperbilirubinemia in infants from the western part of Guangdong ...
Yi-Kang Yang +16 more
doaj +2 more sources
British Journal of Haematology, 2023 Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency in erythrocytes causes acute haemolytic anaemia upon exposure to fava beans, drugs, or infection; and it predisposes to neonatal jaundice.
Lucio Luzzatto
exaly +2 more sources
BMC Pediatrics, 2021 Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency, which may manifest as neonatal hyperbilirubinemia, is the most prevalent erythrocytic enzyme-related disease in the world.
Jia-Xin Xu +8 more
doaj +2 more sources
BMC Pediatrics, 2022 Background Screening for G6PD deficiency in newborns can help prevent severe hemolysis, hyperbilirubinemia, and bilirubin encephalopathy, as recommended by the World Health Organization (WHO).
Thanaporn Pimpakan +9 more
doaj +2 more sources
Human Genomics, 2023 Background G6PD deficiency is a common inherited disorder worldwide and has a higher incidence rate in southern China. Many variants of G6PD result from point mutations in the G6PD gene, leading to decreased enzyme activity.
Ziyan Li +9 more
doaj +2 more sources